Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology
Clémence Deligne, Arthur Tourbez, Flavie Bénard, Swann Meyer, Armin Curt, Matteo Gianesello, Maud Hamadou, Laurent Clavier, Claire Coquet, C Bocquet, Julia Tomine, Thomas Diot, Hermes Paraqindes, Virginie Marcel, Clément Berthelot, J. Engel, Isabelle Rochet, Marc Barritault, Clara Savary, Nicolas Gadot, Valéry Attignon, Marjorie Carrère, Marc Billaud, Aurélie Dutour, Martine Cordier–Bussat, P.A. Beuriat, Alexandru Szathmári, Federico Di Rocco, Jean Yves Blay, Luca Tiberi, Alexandre Vasiljevic, David Meyronet, Marie Castets, Pierre Leblond, Laura Broutier (2025). Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology. , 27(5), DOI: https://doi.org/10.1093/neuonc/noaf007.
Article25 days agoEstablishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology
Clémence Deligne, Arthur Tourbez, Flavie Bénard, Swann Meyer, Armin Curt, Matteo Gianesello, Maud Hamadou, Laurent Clavier, Claire Coquet, C Bocquet, Julia Tomine, Thomas Diot, Hermes Paraqindes, Virginie Marcel, Clément Berthelot, J. Engel, Isabelle Rochet, Marc Barritault, Clara Savary, Nicolas Gadot, Valéry Attignon, Marjorie Carrère, Marc Billaud, Aurélie Dutour, Martine Cordier–Bussat, P.A. Beuriat, Alexandru Szathmári, Federico Di Rocco, Jean Yves Blay, Luca Tiberi, Alexandre Vasiljevic, David Meyronet, Marie Castets, Pierre Leblond, Laura Broutier (2025). Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology. , 27(5), DOI: https://doi.org/10.1093/neuonc/noaf007.
Article25 days agoFusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers
Clara Savary, Léa Luciana, Paul Huchedé, Arthur Tourbez, Claire Coquet, Maëlle Broustal, Alejandro López González, Clémence Deligne, Thomas Diot, Olivier Naret, Mariana Costa, Nina Meynard, Virginie Barbet, Kévin Müller, Laurie Tonon, Nicolas Gadot, Cyril Dégletagne, Valéry Attignon, Sophie Léon, Christophe Vanbelle, Alexandra Bomane, Isabelle Rochet, Virginie Mournetas, Luciana Márcia de Oliveira, Paul Rinaudo, Christophe Bergeron, Aurélie Dutour, Martine Cordier–Bussat, Aline Roch, Nathalie Brandenberg, Sophie El Zein, Sarah Watson, Daniel Orbach, Olivier Delattre, Frédérique Dijoud, Nadège Corradini, Cécile Picard, Delphine Maucort‐Boulch, Marion Le Grand, Eddy Pasquier, Jean Yves Blay, Marie Castets, Laura Broutier (2023). Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers. , 4(12), DOI: https://doi.org/10.1016/j.xcrm.2023.101339.
Article25 days agoFusion-negative Rhabdomyosarcoma 3D-organoids as an innovative model to predict resistance to cell death inducers
Clara Savary, Paul Huchedé, Léa Luciana, Arthur Tourbez, Clémence Deligne, Cécile Picard, Thomas Diot, Claire Coquet, Nina Meynard, Marion Le Grand, Laurie Tonon, Nicolas Gadot, Cyril Dégletagne, Sophie Léon, Valéry Attignon, Alexandra Bomane, Isabelle Rochet, Kévin Müller, Virginie Mournetas, Christophe Bergeron, Paul Rinaudo, Aurélie Dutour, Martine Cordier–Bussat, Frédérique Dijoud, Nadège Corradini, Delphine Maucort‐Boulch, Eddy Pasquier, Jean Yves Blay, Marie Castets, Laura Broutier (2022). Fusion-negative Rhabdomyosarcoma 3D-organoids as an innovative model to predict resistance to cell death inducers. , DOI: https://doi.org/10.1101/2022.09.06.506756.
Preprint20 days ago